NCT01897935CompletedNot Applicable
Flare Photometry in Uveitis Patients
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- ChromoLogic, LLC
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Establish OFAM algorithms for quantitation of ocular flare
Study Overview
Brief Summary
This is a cross sectional study of a novel non-invasive optical flare photometer (OFAM). Patients meeting the inclusion/exclusion criteria will receive a standard eye examination including a slit lamp examination to collect ocular flare data. In addition to the standard eye examination, subjects will receive flare measurements using the OFAM device.
Study Design
- Study Type
- Observational
- Observational Model
- Case Control
- Time Perspective
- Cross Sectional
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Age greater than 18 years
- •Ability to understand and willingness to sign a written informed consent document.
- •To be eligible for the uveitis arm of the study subjects must have active anterior chamber uveitis in one or both eyes as determined by a physician
- •To be eligible for the non-inflammatory arm of the study the study subjects must have no ocular inflammation in either eye as determined by a physician.
Exclusion Criteria
- •Inability to give informed consent
- •Exclusion criteria for the uveitis arm: no active disease
- •Exclusion criteria for the non-inflammatory arm: Signs of uveitis
Outcomes
Primary Outcomes
Establish OFAM algorithms for quantitation of ocular flare
Time Frame: 3 months
OFAM algorithms for quantitation of ocular flare will be established by comparing the output of the OFAM device to the flare measurements obtained during the standard slit lamp examination.
Secondary Outcomes
- Determine the impact that various potential confounders such as age and sex have on OFAM Measurements(3 months)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Imaging of Uveitis Patients Receiving Injectable Fluocinolone Acetonide ImplantUveitisNCT04340505The Cleveland Clinic30
Completed
Not Applicable
Evaluation of Eye Disease with Optical Coherence TomograpyJPRN-UMIN000026307Department of Ophthalmology Tokyo Medical University100
Completed
Not Applicable
ClearPath DS-120 Clinical Study ProtocolOphthalmic, Healthy EyesNCT01425346Freedom Meditech128
Withdrawn
Not Applicable
Optical Frequency Domain Imaging (OFDI) in DermatologyPort Wine StainNCT01438047Massachusetts General Hospital
Terminated
Phase 2
Imaging Characteristics of a Follow-up 18F-AV-1451 ScanAlzheimer's DiseaseNCT02051764Avid Radiopharmaceuticals44